Collegium Pharmaceutical | 10-Q: Q2 2024 Earnings Report
Collegium Pharmaceutical | 8-K: Collegium Reports Second Quarter 2024 Financial Results
Collegium Pharmaceutical | 8-K: Current report
Collegium Pharmaceutical | 8-K: Current report
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kuhlmann Shirley R.
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Tupper Colleen
Collegium Pharmaceutical | 144/A: Others
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Dreyer Scott
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 8-K: Current report
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Collegium Pharmaceutical | 8-K: Current report
No Data